376 related articles for article (PubMed ID: 19546584)
1. Effect of hemodialysis on acid leukocyte-type ribonuclease, alkaline ribonuclease and polymorphonuclear elastase serum levels in patients with end-stage renal disease.
Naskalski JW; Kapusta M; Fedak D; Dumnicka P; Kuśnierz-Cabala B; Kuźniewski M; Sułowicz W
Nephron Clin Pract; 2009; 112(4):c248-54. PubMed ID: 19546584
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
[TBL] [Abstract][Full Text] [Related]
3. Dialysis adequacy, residual renal function and serum concentrations of selected low molecular weight proteins in patients undergoing continuous ambulatory peritoneal dialysis.
Stompór T; Sułowicz W; Anyszek T; Kuśnierz B; Fedak D; Naskalski JW
Med Sci Monit; 2003 Nov; 9(11):CR500-4. PubMed ID: 14586277
[TBL] [Abstract][Full Text] [Related]
4. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients.
Pernice F; Floccari F; Nostro L; Caccamo C; Belghity N; Mantuano S; Romeo A; Barilla' A; Aloisi C; Ruello A; Frisina N; Buemi M
J Nephrol; 2006; 19(5):613-20. PubMed ID: 17136690
[TBL] [Abstract][Full Text] [Related]
6. Determining of actual activities of acid and alkaline ribonuclease in human serum and urine.
Naskalski JW; Celiński A
Mater Med Pol; 1991; 23(2):107-10. PubMed ID: 1842595
[TBL] [Abstract][Full Text] [Related]
7. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
8. Trace element status of chronic renal patients undergoing hemodialysis.
Kiziltas H; Ekin S; Erkoc R
Biol Trace Elem Res; 2008 Aug; 124(2):103-9. PubMed ID: 18414814
[TBL] [Abstract][Full Text] [Related]
9. Convulsions in hemodialysis (HD) patients with elevated polymorphonuclear leukocyte elastase (PMNE) levels.
Nishimura T; Suga T; Takemura F; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1997 May; 22(2):45-51. PubMed ID: 9608630
[TBL] [Abstract][Full Text] [Related]
10. Proteinuria and excretion of ribonuclease in patients with chronic granulocytic leukaemia.
Naskalski JW
Haematologia (Budap); 1987; 20(2):89-99. PubMed ID: 3477519
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects.
Caimi G; Carollo C; Montana M; Iatrino R; Bondì B; Lo Presti R
Blood Purif; 2009; 27(2):194-8. PubMed ID: 19153478
[TBL] [Abstract][Full Text] [Related]
12. Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population.
Turedi S; Cinar O; Yavuz I; Mentese A; Gunduz A; Karahan SC; Topbas M; Cevik E; Yildirim AO; Uzun A; Kaldirim U
J Nephrol; 2010; 23(3):335-40. PubMed ID: 20349416
[TBL] [Abstract][Full Text] [Related]
13. Acid ribonuclease and alkaline ribonuclease isoenzymes in plasma of patients with decreased glomerular filtration rate.
Naskalski J; Anyszek T; Surdacka E; Hoyer B; Sulowicz W
Clin Chem Lab Med; 2004 Mar; 42(3):279-82. PubMed ID: 15080560
[TBL] [Abstract][Full Text] [Related]
14. Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.
Gugliucci A; Lunceford N; Kinugasa E; Ogata H; Schulze J; Kimura S
Clin Chim Acta; 2007 Sep; 384(1-2):105-12. PubMed ID: 17632094
[TBL] [Abstract][Full Text] [Related]
15. Is low blood magnesium level associated with hemodialysis headache?
Goksel BK; Torun D; Karaca S; Karatas M; Tan M; Sezgin N; Benli S; Sezer S; Ozdemir N
Headache; 2006 Jan; 46(1):40-5. PubMed ID: 16412150
[TBL] [Abstract][Full Text] [Related]
16. Oxalic Acid as a uremic toxin.
Mydlík M; Derzsiová K
J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
[TBL] [Abstract][Full Text] [Related]
17. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
[TBL] [Abstract][Full Text] [Related]
18. Soluble receptor for advanced glycation end products in patients with decreased renal function.
Kalousová M; Hodková M; Kazderová M; Fialová J; Tesar V; Dusilová-Sulková S; Zima T
Am J Kidney Dis; 2006 Mar; 47(3):406-11. PubMed ID: 16490618
[TBL] [Abstract][Full Text] [Related]
19. Global assessment of serum antioxidant status in hemodialysis patients.
Mircescu G; Capuşă C; Stoian I; Vârgolici B; Barbulescu C; Ursea N
J Nephrol; 2005; 18(5):599-605. PubMed ID: 16299688
[TBL] [Abstract][Full Text] [Related]
20. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease.
Karamouzis I; Sarafidis PA; Karamouzis M; Iliadis S; Haidich AB; Sioulis A; Triantos A; Vavatsi-Christaki N; Grekas DM
Am J Nephrol; 2008; 28(3):397-404. PubMed ID: 18063858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
